Skip to main content
Premium Trial:

Request an Annual Quote

Tripos Shares Rally on Abbot Deal

NEW YORK, March 21 (GenomeWeb News) - Tripos shares were up 5 percent, or $.14, at $2.89 after Tripos said it would collaborate with Abbott to make compounds.


The two firms will collaborate in library design, analysis and synthesis, according to a release.


Financial details were not released.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.